Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Pass Above Fifty Day Moving Average - Here's What Happened

Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $10.29 and traded as high as $11.70. Ono Pharmaceutical shares last traded at $11.70, with a volume of 3,098 shares traded.

Ono Pharmaceutical Stock Up 0.9 %

The firm has a market capitalization of $5.55 billion, a P/E ratio of 11.36 and a beta of 0.57. The firm's fifty day moving average price is $10.41 and its 200-day moving average price is $11.09. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.55 and a quick ratio of 2.80.

Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a return on equity of 9.10% and a net margin of 15.15%.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.